Swine Respiratory Diseases Treatment Market - Global Outlook and Forecast 2021-2027

April 2021 | 105 pages | ID: SBE6AC60B6D6EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Swine Respiratory Diseases Treatment in Global, including the following market information:

Global Swine Respiratory Diseases Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Swine Respiratory Diseases Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Swine Respiratory Diseases Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Swine Respiratory Diseases Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Swine Respiratory Diseases Treatment Market Segment Percentages, By Type, 2020 (%)

• By Causative Agent
• Mycoplasma
• Bacteria
• Virus
• Others
• By Treatment Type
• Vaccines
• Drugs
• By Administration
• Parenteral
• Oral

China Swine Respiratory Diseases Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Swine Respiratory Diseases Treatment Market Segment Percentages, By Application, 2020 (%)

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies
• Others

Global Swine Respiratory Diseases Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Swine Respiratory Diseases Treatment Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Swine Respiratory Diseases Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Swine Respiratory Diseases Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Zoetis
• Virbac
• Eli Lilly(Elanco)
• Merck Animal Health
• Boehringer Ingelheim
• Ceva Sante Animale
• Norbrook
• Thermo Fisher Scientific Inc
• Vetoquinol
• Bimeda holdings PLC
• Huvepharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Autoimmune Hemolytic Anemia Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Autoimmune Hemolytic Anemia Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL AUTOIMMUNE HEMOLYTIC ANEMIA THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Autoimmune Hemolytic Anemia Therapeutics Market Size: 2021 VS 2027
2.2 Global Autoimmune Hemolytic Anemia Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Autoimmune Hemolytic Anemia Therapeutics Players in Global Market
3.2 Top Global Autoimmune Hemolytic Anemia Therapeutics Companies Ranked by Revenue
3.3 Global Autoimmune Hemolytic Anemia Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Autoimmune Hemolytic Anemia Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Autoimmune Hemolytic Anemia Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Autoimmune Hemolytic Anemia Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Autoimmune Hemolytic Anemia Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Autoimmune Hemolytic Anemia Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Autoimmune Hemolytic Anemia Therapeutics Market Size Markets, 2021 & 2027
  4.1.2 Corticosteroids
  4.1.3 Monoclonal Antibodies
  4.1.4 Others
4.2 By Type - Global Autoimmune Hemolytic Anemia Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Autoimmune Hemolytic Anemia Therapeutics Revenue, 2016-2021
  4.2.2 By Type - Global Autoimmune Hemolytic Anemia Therapeutics Revenue, 2022-2027
  4.2.3 By Type - Global Autoimmune Hemolytic Anemia Therapeutics Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Autoimmune Hemolytic Anemia Therapeutics Market Size, 2021 & 2027
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Autoimmune Hemolytic Anemia Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Autoimmune Hemolytic Anemia Therapeutics Revenue, 2016-2021
  5.2.2 By Application - Global Autoimmune Hemolytic Anemia Therapeutics Revenue, 2022-2027
  5.2.3 By Application - Global Autoimmune Hemolytic Anemia Therapeutics Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Autoimmune Hemolytic Anemia Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Autoimmune Hemolytic Anemia Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Autoimmune Hemolytic Anemia Therapeutics Revenue, 2016-2021
  6.2.2 By Region - Global Autoimmune Hemolytic Anemia Therapeutics Revenue, 2022-2027
  6.2.3 By Region - Global Autoimmune Hemolytic Anemia Therapeutics Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Autoimmune Hemolytic Anemia Therapeutics Revenue, 2016-2027
  6.3.2 US Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027
  6.3.3 Canada Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027
  6.3.4 Mexico Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Autoimmune Hemolytic Anemia Therapeutics Revenue, 2016-2027
  6.4.2 Germany Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027
  6.4.3 France Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027
  6.4.4 U.K. Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027
  6.4.5 Italy Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027
  6.4.6 Russia Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027
  6.4.7 Nordic Countries Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027
  6.4.8 Benelux Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Autoimmune Hemolytic Anemia Therapeutics Revenue, 2016-2027
  6.5.2 China Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027
  6.5.3 Japan Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027
  6.5.4 South Korea Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027
  6.5.5 Southeast Asia Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027
  6.5.6 India Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Autoimmune Hemolytic Anemia Therapeutics Revenue, 2016-2027
  6.6.2 Brazil Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027
  6.6.3 Argentina Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Revenue, 2016-2027
  6.7.2 Turkey Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027
  6.7.3 Israel Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027
  6.7.4 Saudi Arabia Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027
  6.7.5 UAE Autoimmune Hemolytic Anemia Therapeutics Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Amneal Pharmaceuticals Inc
  7.1.1 Amneal Pharmaceuticals Inc Corporate Summary
  7.1.2 Amneal Pharmaceuticals Inc Business Overview
  7.1.3 Amneal Pharmaceuticals Inc Autoimmune Hemolytic Anemia Therapeutics Major Product Offerings
  7.1.4 Amneal Pharmaceuticals Inc Autoimmune Hemolytic Anemia Therapeutics Revenue in Global (2016-2021)
  7.1.5 Amneal Pharmaceuticals Inc Key News
7.2 Baxter International Inc
  7.2.1 Baxter International Inc Corporate Summary
  7.2.2 Baxter International Inc Business Overview
  7.2.3 Baxter International Inc Autoimmune Hemolytic Anemia Therapeutics Major Product Offerings
  7.2.4 Baxter International Inc Autoimmune Hemolytic Anemia Therapeutics Revenue in Global (2016-2021)
  7.2.5 Baxter International Inc Key News
7.3 F. Hoffmann-La Roche Ltd
  7.3.1 F. Hoffmann-La Roche Ltd Corporate Summary
  7.3.2 F. Hoffmann-La Roche Ltd Business Overview
  7.3.3 F. Hoffmann-La Roche Ltd Autoimmune Hemolytic Anemia Therapeutics Major Product Offerings
  7.3.4 F. Hoffmann-La Roche Ltd Autoimmune Hemolytic Anemia Therapeutics Revenue in Global (2016-2021)
  7.3.5 F. Hoffmann-La Roche Ltd Key News
7.4 Incyte Corp
  7.4.1 Incyte Corp Corporate Summary
  7.4.2 Incyte Corp Business Overview
  7.4.3 Incyte Corp Autoimmune Hemolytic Anemia Therapeutics Major Product Offerings
  7.4.4 Incyte Corp Autoimmune Hemolytic Anemia Therapeutics Revenue in Global (2016-2021)
  7.4.5 Incyte Corp Key News
7.5 Kezar Life Sciences Inc
  7.5.1 Kezar Life Sciences Inc Corporate Summary
  7.5.2 Kezar Life Sciences Inc Business Overview
  7.5.3 Kezar Life Sciences Inc Autoimmune Hemolytic Anemia Therapeutics Major Product Offerings
  7.5.4 Kezar Life Sciences Inc Autoimmune Hemolytic Anemia Therapeutics Revenue in Global (2016-2021)
  7.5.5 Kezar Life Sciences Inc Key News
7.6 Pfizer Inc
  7.6.1 Pfizer Inc Corporate Summary
  7.6.2 Pfizer Inc Business Overview
  7.6.3 Pfizer Inc Autoimmune Hemolytic Anemia Therapeutics Major Product Offerings
  7.6.4 Pfizer Inc Autoimmune Hemolytic Anemia Therapeutics Revenue in Global (2016-2021)
  7.6.5 Pfizer Inc Key News
7.7 Rigel Pharmaceuticals Inc
  7.7.1 Rigel Pharmaceuticals Inc Corporate Summary
  7.7.2 Rigel Pharmaceuticals Inc Business Overview
  7.7.3 Rigel Pharmaceuticals Inc Autoimmune Hemolytic Anemia Therapeutics Major Product Offerings
  7.4.4 Rigel Pharmaceuticals Inc Autoimmune Hemolytic Anemia Therapeutics Revenue in Global (2016-2021)
  7.7.5 Rigel Pharmaceuticals Inc Key News
7.8 Sanofi
  7.8.1 Sanofi Corporate Summary
  7.8.2 Sanofi Business Overview
  7.8.3 Sanofi Autoimmune Hemolytic Anemia Therapeutics Major Product Offerings
  7.8.4 Sanofi Autoimmune Hemolytic Anemia Therapeutics Revenue in Global (2016-2021)
  7.8.5 Sanofi Key News
7.9 Teva Pharmaceutical Industries Ltd
  7.9.1 Teva Pharmaceutical Industries Ltd Corporate Summary
  7.9.2 Teva Pharmaceutical Industries Ltd Business Overview
  7.9.3 Teva Pharmaceutical Industries Ltd Autoimmune Hemolytic Anemia Therapeutics Major Product Offerings
  7.9.4 Teva Pharmaceutical Industries Ltd Autoimmune Hemolytic Anemia Therapeutics Revenue in Global (2016-2021)
  7.9.5 Teva Pharmaceutical Industries Ltd Key News
7.10 Horizo??n
  7.10.1 Horizo??n Corporate Summary
  7.10.2 Horizo??n Business Overview
  7.10.3 Horizo??n Autoimmune Hemolytic Anemia Therapeutics Major Product Offerings
  7.10.4 Horizo??n Autoimmune Hemolytic Anemia Therapeutics Revenue in Global (2016-2021)
  7.10.5 Horizo??n Key News
7.11 Genentech
  7.11.1 Genentech Corporate Summary
  7.11.2 Genentech Business Overview
  7.11.3 Genentech Autoimmune Hemolytic Anemia Therapeutics Major Product Offerings
  7.11.4 Genentech Autoimmune Hemolytic Anemia Therapeutics Revenue in Global (2016-2021)
  7.11.5 Genentech Key News
7.12 Zydus Cadila
  7.12.1 Zydus Cadila Corporate Summary
  7.12.2 Zydus Cadila Business Overview
  7.12.3 Zydus Cadila Autoimmune Hemolytic Anemia Therapeutics Major Product Offerings
  7.12.4 Zydus Cadila Autoimmune Hemolytic Anemia Therapeutics Revenue in Global (2016-2021)
  7.12.5 Zydus Cadila Key News
7.13 Concord Biotech
  7.13.1 Concord Biotech Corporate Summary
  7.13.2 Concord Biotech Business Overview
  7.13.3 Concord Biotech Autoimmune Hemolytic Anemia Therapeutics Major Product Offerings
  7.13.4 Concord Biotech Autoimmune Hemolytic Anemia Therapeutics Revenue in Global (2016-2021)
  7.13.5 Concord Biotech Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Swine Respiratory Diseases Treatment Market Opportunities & Trends in Global Market
Table 2. Swine Respiratory Diseases Treatment Market Drivers in Global Market
Table 3. Swine Respiratory Diseases Treatment Market Restraints in Global Market
Table 4. Key Players of Swine Respiratory Diseases Treatment in Global Market
Table 5. Top Swine Respiratory Diseases Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Swine Respiratory Diseases Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Swine Respiratory Diseases Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Swine Respiratory Diseases Treatment Product Type
Table 9. List of Global Tier 1 Swine Respiratory Diseases Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Swine Respiratory Diseases Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Swine Respiratory Diseases Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Swine Respiratory Diseases Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Swine Respiratory Diseases Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Swine Respiratory Diseases Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Swine Respiratory Diseases Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Swine Respiratory Diseases Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Zoetis Corporate Summary
Table 31. Zoetis Swine Respiratory Diseases Treatment Product Offerings
Table 32. Zoetis Swine Respiratory Diseases Treatment Revenue (US$, Mn), (2016-2021)
Table 33. Virbac Corporate Summary
Table 34. Virbac Swine Respiratory Diseases Treatment Product Offerings
Table 35. Virbac Swine Respiratory Diseases Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Eli Lilly(Elanco) Corporate Summary
Table 37. Eli Lilly(Elanco) Swine Respiratory Diseases Treatment Product Offerings
Table 38. Eli Lilly(Elanco) Swine Respiratory Diseases Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Merck Animal Health Corporate Summary
Table 40. Merck Animal Health Swine Respiratory Diseases Treatment Product Offerings
Table 41. Merck Animal Health Swine Respiratory Diseases Treatment Revenue (US$, Mn), (2016-2021)
Table 42. Boehringer Ingelheim Corporate Summary
Table 43. Boehringer Ingelheim Swine Respiratory Diseases Treatment Product Offerings
Table 44. Boehringer Ingelheim Swine Respiratory Diseases Treatment Revenue (US$, Mn), (2016-2021)
Table 45. Ceva Sante Animale Corporate Summary
Table 46. Ceva Sante Animale Swine Respiratory Diseases Treatment Product Offerings
Table 47. Ceva Sante Animale Swine Respiratory Diseases Treatment Revenue (US$, Mn), (2016-2021)
Table 48. Norbrook Corporate Summary
Table 49. Norbrook Swine Respiratory Diseases Treatment Product Offerings
Table 50. Norbrook Swine Respiratory Diseases Treatment Revenue (US$, Mn), (2016-2021)
Table 51. Thermo Fisher Scientific Inc Corporate Summary
Table 52. Thermo Fisher Scientific Inc Swine Respiratory Diseases Treatment Product Offerings
Table 53. Thermo Fisher Scientific Inc Swine Respiratory Diseases Treatment Revenue (US$, Mn), (2016-2021)
Table 54. Vetoquinol Corporate Summary
Table 55. Vetoquinol Swine Respiratory Diseases Treatment Product Offerings
Table 56. Vetoquinol Swine Respiratory Diseases Treatment Revenue (US$, Mn), (2016-2021)
Table 57. Bimeda holdings PLC Corporate Summary
Table 58. Bimeda holdings PLC Swine Respiratory Diseases Treatment Product Offerings
Table 59. Bimeda holdings PLC Swine Respiratory Diseases Treatment Revenue (US$, Mn), (2016-2021)
Table 60. Huvepharma Corporate Summary
Table 61. Huvepharma Swine Respiratory Diseases Treatment Product Offerings
Table 62. Huvepharma Swine Respiratory Diseases Treatment Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Swine Respiratory Diseases Treatment Segment by Type
Figure 2. Swine Respiratory Diseases Treatment Segment by Application
Figure 3. Global Swine Respiratory Diseases Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Swine Respiratory Diseases Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Swine Respiratory Diseases Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Swine Respiratory Diseases Treatment Revenue in 2020
Figure 8. By Type - Global Swine Respiratory Diseases Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Swine Respiratory Diseases Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Swine Respiratory Diseases Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Swine Respiratory Diseases Treatment Revenue Market Share, 2016-2027
Figure 12. US Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Swine Respiratory Diseases Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Swine Respiratory Diseases Treatment Revenue Market Share, 2016-2027
Figure 24. China Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Swine Respiratory Diseases Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Swine Respiratory Diseases Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Swine Respiratory Diseases Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Zoetis Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Virbac Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Eli Lilly(Elanco) Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Merck Animal Health Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Boehringer Ingelheim Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Ceva Sante Animale Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Norbrook Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Thermo Fisher Scientific Inc Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Vetoquinol Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Bimeda holdings PLC Swine Respiratory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)